Curis to present at Techvest Conference in November:
Techvest and NJ Center for Biomaterials Announce Three Days of Tissue Engineering in NY/NJ
Business Wire - June 26, 2000 07:17
Jump to first matched term
NEW YORK--(BW HealthWire)--June 26, 2000--Techvest, LLC and the New Jersey Center for Biomaterials today announced an affiliation between their respective conferences on tissue engineering and biomaterials.
Joint registration for Techvest's 2nd Annual Conference on Tissue Repair, Replacement and Regeneration, to be held November 8-9 in New York City, and for the 5th New Jersey Symposium on Biomaterials Science, to be held November 9-10 in Somerset, New Jersey, is available through the Techvest conference web site at tissueconference.com or by contacting Techvest. Transportation between the two events will be provided.
"This is no doubt the biggest event in tissue engineering, appealing equally to investors, senior industry executives, research scientists and clinicians," said Michael Ehrenreich, President of Techvest.
The Techvest conference, which will feature presentations from 50 thought-leading companies, both public and private, in the fields of tissue engineering, growth factors, cell therapy, gene therapy, xenotransplantation and biomaterials, is intended for institutional investors, venture capitalists, accredited investors, business development officers, and academic and medical professionals interested in the field.
The 5th New Jersey Symposium on Biomaterials Science is targeted at executives working in research, development and marketing of medical implants, academic and industrial scientists, and clinicians who use biomaterials in their practice. The symposium will feature six theme sessions covering: Material Needs; Novel Approaches to Biomaterials Design; New Materials for Drug and Gene Delivery; Materials for Specific Applications; The Basic Science of Cell-Material Interactions; and Moving Tissue Regeneration Therapies Toward Clinical Application. The keynote speaker will be Dr. Joseph Vacanti of Massachusetts General Hospital, a world leader in developing tissue engineering therapies.
"The 5th New Jersey Symposium on Biomaterials Science and the Techvest conference are a perfect match, combining the perspectives of a world class academic center and a leading biotech investment bank," said Dr. Joachim Kohn, Director of the New Jersey Center for Biomaterials.
Companies scheduled to present at the Techvest conference include:
Aastrom Biosciences (NASDAQ:ASTM), Advanced Tissue Sciences (NASDAQ:ATIS), Anika Therapeutics (NASDAQ:ANIK), Ariad Pharmaceuticals (NASDAQ:ARIA), Bioheart Inc., Biora AB (NASDAQ:BIORY), Boston Life Sciences (NASDAQ:BLSI), co.don, Inc., Collagenesis, CryoLife (NYSE:CRY), Curis (NASDAQ:CRIS), Encelle, Etex Corp., FibroGen, Fidia Advanced Biopolymers, GenSci Regeneration Sciences (TSE:GNS), Genzyme BioSurgery (NASDAQ:GZBX), Geron Corporation (NASDAQ:GERN), INAMED Corp. (NASDAQ:IMDC), Integra LifeSciences (NASDAQ:IART), Ixion Biotechnology, LifeCell (NASDAQ:LIFC), Modex Therapeutiques, NeoTherapeutics (NASDAQ:NEOT), Nephros, Neuronyx, Nexell Therapeutics (NASDAQ:NEXL), Organogenesis (AMEX:ORG), Organ Recovery Systems, Orquest, Ortec Intn'l (NASDAQ:ORTC), Osiris Therapeutics, Osteotech (NASDAQ:OSTE), Protein Polymer Teschnologies (OTC BB:PPTI), Regen Biologics, Regeneration Technologies Inc., Selective Genetics, Stem Cell Sciences Ltd., Targeted Genetics (NASDAQ:TGEN), Tissue Engineering Inc., Tissue Transformation Technologies, Titan Pharmaceuticals (AMEX:TTP), and Tutogen Medical (OTC BB:TTGN).
Institutional investors and venture capitalists should contact Peter Hardy at 212-262-4646 Ext. 113 or e-mail to pahardy@techvestllc.com for registration.
Techvest, LLC is an investment bank specializing in the healthcare sector.
The New Jersey Center for Biomaterials is a cooperative research initiative sponsored by the University of Medicine and Dentistry of New Jersey, Rutgers-the State University of New Jersey, and New Jersey Institute of Technology, in coordination with Princeton University and the Associated Institutions for Material Sciences. The Center receives major support from the New Jersey Commission on Science and Technology.
CONTACT: Techvest
Michael Ehrenreich, 212/262-4646 ext.106
techvest@techvestllc.com
techvestllc.com
tissueconference.com
or
New Jersey Center for Biomaterials
Carole Kantor, 732/445-0488
cbmd@rutchem.rutgers.edu
rutchem.rutgers.edu
|
